Cargando…
Chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer patients: is it time for additional evidence?
Recent efforts to improve survival in patients with locally advanced esophageal carcinoma have combined both systemic and local therapy. However, the role of neoadjuvant chemoradiotherapy in technically operable IIa-III esophageal carcinoma is still unresolved.
Autores principales: | Cafarotti, Stefano, Cesario, Alfredo, Porziella, Venanzio, Margaritora, Stefano, Granone, Pierluigi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103440/ https://www.ncbi.nlm.nih.gov/pubmed/21504620 http://dx.doi.org/10.1186/1477-7819-9-41 |
Ejemplares similares
-
Rationale and clinical benefits of an intensive long-term pulmonary rehabilitation program after oesophagectomy: preliminary report
por: Lococo, Filippo, et al.
Publicado: (2012) -
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node‐negative esophageal carcinoma
por: Gao, Hui‐Jiang, et al.
Publicado: (2020) -
Chest wall tumors and prosthetic reconstruction: A comparative analysis on functional outcome
por: Leuzzi, Giovanni, et al.
Publicado: (2015) -
High-dose chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer: a retrospective cohort study
por: Hurmuzlu, Meysan, et al.
Publicado: (2010) -
EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
por: Antonicelli, Alberto, et al.
Publicado: (2013)